Skip to main content

Table 4 Association between repair vs replacement and mortality within subgroups

From: Should more patients be offered repair for mitral valve endocarditis? a single-centre 15-year experience

 

N

No. of events (%)

Model 1

Model 2

Model 3

HR (95% CI)

HR (95% CI)

HR (95% CI)

Healed Endocarditis

 MVr

34

8 (23.5)

Reference

Reference

Reference

 MVR

14

4 (30.8)

1.47 (0.44–4.89)

0.75 (0.19–2.89)

1.62 (0.46–5.73)

Active Endocarditis

 MVr

51

12 (23.5)

Reference

Reference

Reference

 MVR

84

23 (27.7)

1.10 (0.54–2.21)

1.09 (0.54–2.20)

0.85 (0.41–1.77)

Elective

 MVr

23

1 (4.4)

Reference

Reference

Reference

 MVR

8

2 (25.0)

6.72 (0.61–74.48)

6.70 (0.61–74.09)

6.80 (0.58–79.25)

Non-Elective

 MVr

62

19 (30.7)

Reference

Reference

Reference

 MVR

90

25 (28.4)

0.84 (0.46–1.53)

0.90 (0.48–1.68)

0.63 (0.34–1.18)

  1. Model 1: univariate analysis; Model 2: urgency adjusted in endocarditis subgroups, active endocarditis adjusted in urgency subgroups; Model 3: logistic EuroSCORE adjusted only
  2. MVr mitral valve repair, MVR mitral valve replacement, IE infective endocarditis
  3. P-interaction for endocarditis = 0.859
  4. P-interaction for urgency = 0.122